No Data
Insider Purchase: Director at $AVIR (AVIR) Buys 15,000 Shares
Atea Pharmaceuticals to Highlight 2025 Strategic Priorities
Express News | Atea Pharmaceuticals Inc - Reports Cash Balance of $454.7 Million at Dec 31, 2024
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Express News | Bradley L. Radoff and Michael Torok: Collectively Own About 3% of Outstanding Shares of Atea Pharmaceuticals
Concerned Shareholder Group Calls for Atea Pharmaceuticals to Appoint a New, Shareholder-Oriented Lead Independent Director to Oversee Strategic Review Process
No Data
Arrayfunction : With the +27% cash from financing last quarter, is this corporate speak for "insiders seek greater fool to dump this sinking ship on?"
Jaguar8 OP Arrayfunction : We shall see how it unfolds